Patients with a history of intracranial hemorrhage have had few safe treatment options for nonvalvular atrial fibrillation. A new study of the Watchman device suggests that may be changing.
Findings from three Cleveland Clinic real-world studies suggest a wider range of patients stand to benefit from the left atrial appendage closure device.
The new Centers for Medicare & Medicaid Services proposal restricting reimbursement for the WATCHMAN device may help prevent abuse, but it’s too limiting. Cleveland Clinic experts share their take.
Five new technologies — subcutaneous ICDs, contact force ablation catheters, leadless pacemakers, a vagal nerve stimulator and a left atrial appendage occlusion device — are making EP procedures safer and more effective.